Refine by
Biomarker Analysis Articles & Analysis
20 news found
For cell and molecular biology research, R-PE labeled protein can be used as a biomarker in cellular immune analysis, and can also be used as a fluorescent marker in the research of many cells, cell components and related molecules. For Biomedical research, R-PE labeled proteins can be used as fluorescent probes for drug efficacy, biological molecular components, ...
With a commitment to quality and excellence, Alfa Chemistry offers pharmacological analysis, drug safety evaluation, pharmacokinetic analysis, and bioanalytical services to streamline the drug development process and ensure the safety and efficacy of potential new therapeutics. ...
The product manager is pleased to announce the launch of its Microbial Biomarker Discovery service, a revolutionary solution that promises to transform microbiology research. ...
Data from the MANIFEST trial show durable improvements in both spleen volume and symptom score beyond 24 weeks with pelabresib in combination with ruxolitinib for JAK inhibitor-naïve patients An exploratory analysis of biomarkers from the MANIFEST trial indicates the potential for disease modification MorphoSys AG (FSE: MOR; NASDAQ: MOR) today ...
These latest imaging biomarkers strengthen VIDA’s portfolio of airway, tissue, vascular and functional measures. VIDA’s latest airway biomarkers include mucus plug scoring, bronchiectasis scoring, and total airway count (TAC). ...
This feature provides a comprehensive, consistent, and automated analysis of biomarkers from next-generation sequencing (NGS) and microarray data that can help clinical researchers stratify therapeutic response across multiple tumor types. ...
THE KIT OFFERS A COMPLETE WORKFLOW SOLUTION WHICH ENABLES LABORATORIES WITH NGS CAPABILITIES TO PERFORM COMPREHENSIVE BIOMARKER TESTING, PROVIDE POWERFUL DATA ANALYSIS AND SUPPORT ONCOLOGISTS IN THE MOST EFFECTIVE AND PERSONALIZED TREATMENTS FOR THEIR CANCER PATIENTS. THE ONCODEEP KIT INTEGRATES BOTH REAGENTS AND QUALITY CONTROL STANDARDS FOR THE SEQUENCING OF ...
Analysis of biomarkers by bioinformatics can provide data support for experiments to a large extent, thereby speeding up research progress and reducing research costs. With years of data analysis experience, CD Genomics provides you with a wide range of biomarker and target discovery data analysis services. ...
New Guardant Reveal™ data from interim analysis of COSMOS-CRC-01 demonstrates high performance for recurrence detection in early-stage colorectal cancer REDWOOD CITY, ...
CD Genomics provides a wide range of services such as genome sequencing, RNA sequencing, epigenomics sequencing, genotyping, as well as integrated portfolios of multiple sequencing services. Integration analysis of multiple sequencing data provides a broader view of the genomics research, which comes extremely handy in gene expression and regulation analysis, ...
The product manager has recently announced the fully-developed exosomes lipidomics service to help identify lipid-based biomarkers and unravel its monitoring function in diseases. Exosomes are considered to be a new and effective intercellular communication carrier. ...
Tethis’ technology points to standardization of the blood sample preparation to provide the highest quality and integrity of liquid biopsy specimens for the comprehensive analysis of clinically informative biomarkers. The company’s proprietary nanocoated slides combined with the automated pre-analytical instrument allow to identify and characterize ...
Tymora’s focus is on providing diagnostic and therapeutic biomarker discovery contract services and products. Together, they will aim to enrich and measure circulating biomarkers for use in non-invasive early-stage Alzheimer’s Disease(AD) diagnostics and other applications in the global life sciences research and clinical in vitro diagnostics markets. ...
Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology investigates biomarkers at the structural level as opposed to overall concentration, giving better insights as to the protein origin. ...
Santa Cruz, CA, September 2018 - SomaGenics announced today the issue of US Patent 10,041,107, a continuation of SomaGenics’ patent family entitled “Methods and Compositions for Detection of small RNAs.” The new patent broads protection for SomaGenics’ innovative, circularization-based approaches to accurately detect and quantify small RNAs, including key ...
“The technology underlying IsoPSA™ represents a transformational departure in how cancer biomarkers are defined. Instead of asking the non-specific question of how much of a biomarker, such as PSA, is circulating in blood, our test essentially identifies the type of PSA that originates only from cancer cells,” said Chait. ...
(known as MSD outside the United States and Canada, through an affiliate) to develop a companion diagnostic test for the analysis of the potential tumor biomarker PD-L1 to aid in the treatment of cancer. ...
"We are excited about bringing BioSystem Development, a valued partner, into Agilent," said Fred Strohmeier, vice president and general manager of Agilent's Liquid Phase Analysis Division within the company's Life Sciences Group. "BioSystem Development's innovative and versatile microchromatography technology, and the team's applications expertise, will help Agilent expand its ...
The cluster will conduct the START (Stroke, imaging, pRevention and Treatment) cohort study of stroke which is designed to integrate imaging and biomarker analysis to identify patients at risk of stroke. Those strategies will then be used to develop preventative measures for those patients. ...
Mary Lopez, Ph.D., Business Leader for Analytical Proteomics at PerkinElmer presented the results on Thursday, April 14, 2005 at AACC's Oak Ridge Conference in Baltimore , Maryland . The blood analysis was carried out using PerkinElmer's BioXPRESSION™ Biomarker platform and Predictive Diagnostic's proprietary BAMF™ technology to identify patterns of proteins and ...